PNG  IHDRcsRGBgAMA a pHYsodzIDATx^흋{EW9ϒ5drzpϮH!!BYI@@A% ADM xV%~;Lw{jz&3igwzkb7әr|A5k`HP\p`0$ f` L  ݻwL3 U#Q"mAF~|n)' р[ #w/hNZ400 YxhF O6FDF˯`LJx Q5%2Os߆;~C4FHhZ>O,n+Z~C4FHh6lm א\*oo3dlT 5C=99'gVm?5HR|#xvL(#99xj[~CFS+zIHOO ss M@Mn.ue@SCFύo'N[Fsh/&}I!`jāSRNv;KFύf?3Q_:T4ǐ>Q52HmK8ϵ; Ax񢔂e@#_X '9Gzd+?^,L}ƕáH!s`j!D0DGQܑIu3r zȨh w5dlT8!2CBLs$jRMyOyp3k%Ut~CFHؗa;tug;vԤyl9ڶݤ~0ֺ+dp^qH1dlTb$BZt%)1us0a6P7{y[T>qaZ_|((H6 VKÄ}3R6FDƂtT?W Q6"/9 J;=o ͪ-'lT82Hێ4RDnR]CcZOȟ@"$귚|DM*ryUBV!Si/=${`RŚ C5҂$鷚Kݵv7 ҷ G\l,]ʶo ߂/c^ȟ39 OMǟHO6@ļ<6jR#'{EG\l,/ɯn?'ZLt IV(ZwHy|i݈ 6F-uLj fR,L<*dc}a4w%<_럴t߹a`d//inGx/1r› Q5u8!AK7>]>W! GܕՈks{FVj{@qcI{xcon&(`j$Jd$H- ؿ*dc}a4~ @hT>}+rR6Fl&߂Շ*qӅAr‚ 7IEoo(Zl,/j~&o#Lب:Lrh~j*?Nxv$-YQ5}dݍ7H _ecoGGl1G\l,/j~I1.]B.بJ5EoA'ӿ*dc}a4]?Ws5?-jr~kb U#Q)j~㟱rlr /,o[W! U_w}x[e5D-P5l)9Mt\-g-tlTDaRO\1Q! ʏls aZMNATrh~j~cj$k-汯F5v6i ۷8p Bs5]?WSQ55~ߓ=H<kCNATrh~j~cj$kAڶ<߸tt\Mt\MFHtۆ*بaz~r B6Fs5]?Ws5U#Q)j~j*?6FDZtΝVmt&:*dc}a4]?Ws5]?WSQ5%DfϞ )y [xar B6Fs5]?Ws5U#Q3dj~j*?6FİJ7%'ݿ *dc}a4]?Ws5]?WSQ52DȭdE V!e=n=ȟN lwMkaΦ^r B6Fs5]?Ws5U#ȑZj?8xjssu~rm_y?͘ t\Mt\MFՈۭЎA aҳ VN_ܾ0بq)00>#vڅt"T^^/^L)~zd'sܾ0بq8+Tv(tZ(vʓc %ʏ"H9P؎kW9J<=ڟ=HӖ%'ݿ *dc}a4]?WKcPبADܗgϮb^xbኁa?,tҥK)$tI/ Xn_Mt\MT~lTrl8Fe)&H!4]?Ws5]?WSQ5%{y|:.&ݿ *dc}a4]?Ws5]?WSQ5%5HšI/ Xn_Mt\MT~lTD 9s˗S 64]?Ws5U#Q34lA:-{ieDl,/j~j*?6FİЉ~0{uDl,/j~j*?6F RMt\MT~lTD 'HW\I)~W]G~':*dc}a4]?Ws5]?WSQ5%5H= T8Q! ʏ(!4w\zjJfj~cj$J`-H[?NATrh~j~cj$J5H$j~cjdPЛpQhǐ(U<'H׮]K)Lt\MT~lT yϫ^ڵ^˃^뼷l<:d43AZ -8Q! ʏiw@Ӈ!F L?ͤ5HMm &;ht\Mt\MFՈ,H>nc}Ẵ+PӉҼy)?HVl_8Q! ʏ띱FvN<,޸ğf0C.Y'%I/ Xn_Mt\MT~lT8AvN;Ӊ7nl MX O+p B6Fs5]?Ws5U#l ',%A7I+NATrh~j~cj$J t\Mt\MFHA?>ܼy3ड़iaZj$J`$~`HNnݺe0`HT#8o1bAtvBq\MƼ!bb)h̋Nr{X5r<_@+b%Awn5Mw:Ms`tSu_brG=~\}֘b{xka7լK`'3>ܓ| EM+>6a}y5뒕 = RXeTמu{7EWka% h^ͺd%;N3I΋ݿ~󹑍\ j%+A=Gwbw|w %zb{|SW܃zN t@q?{=&x^ͺd"H g讝{F;:VBb|ĵ1 ]c^Wj%ՙod;@c%ӈ UTTݻw C`L 8Ad`H&HC 0Abzn #Rxa p„@-ֺK0ê3.-b!`LT|]ݵJ)~|L[Ґm iHv3  wo) i O_}na$T(, zwu=1gq iA>zn ~w\_9?_ ͮ X]/+󄯿97fQ  )@2{5 |0C&HCH A0 L  hѢ? ei%0C9F'!9F20IENDB` Padmakshi Financial Services
linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
   
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.